Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy

Journal of the American College of Cardiology

Volumn 29, Issue 4, 1997, Pages 716-724

  Satoh, Mamoru ^a   Nakamura, Motoyuki ^a   Tamura, Gen ^a   Makita, Shinji ^a   Segawa, Ikuo ^a   Tashiro, Atsushi ^a   Satodate, Ryoichi ^a   Hiramori, Katsuhiko ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; BIOPSY; BLOTTING, SOUTHERN; CARDIOMYOPATHY, DILATED; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYOCARDIUM; NITRIC OXIDE SYNTHASE; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030933069     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00567-0     Document Type: Article

References (46)

1. Smith JA, Radomski MW, Schulz R, Moncada S, Lewis MJ. Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase. Br J Pharmacol. 108:1993;1107-1110.
2. Tsujino M, Hirata Y, Imai T, et al. Induction of nitric oxide synthase gene by interleukin-1β in cultured rat cardiocytes. Circulation. 90:1994;375-383.
3. Shindo T, Ikeda U, Ohkawa F, Kawahara Y, Yokoyama M, Shimada K. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res. 29:1995;813-819.
4. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduced their contractility in endotoxemia. Am J Physiol. 263:1992;H1963-6.
5. Brutsaert DL, Andries LJ. The endocardial endothelium. Am J Physiol. 263:1992;H985-1002.
6. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 105:1992;575-580.
7. Kornbluth RS, Edgington T. Tumor necrosis factor production by human monocytes is a regulated event induction of TNF-α-mediated cellular cytotoxicity by endotoxin . J Immunol. 137:1986;2585-2591.
8. Anggard E. Nitric oxide mediator, murderer, and medicine . Lancet. 343:1994;1199-1206.
9. de Belder AJ, Radomski MW, Martin JF, Moncada S. Nitric oxide and the pathogenesis of heart muscle disease. Eur J Clin Invest. 24:1995;1-8.
10. de Belder AJ, Radomski MW, Why HJF, et al. Nitric oxide synthase activities in human myocardium. Lancet. 341:1993;84-85.
11. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980;44:672-3.
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
13. Charles IG, Palmer RMJ, Hickery MS, et al. Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA. 90:1993;11419-11423.
14. Shirai T, Yamaguchi H, Ito H, Todd CW, Wallace RB. Cloning and expression in Escherichia coli of the gene for human tumor necrosis factor. Nature. 313:1985;803-806.
15. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic β-actin gene interspecies homology of sequences in the introns . Proc Natl Acad Sci USA. 82:1985;6133-6137.
16. Bowles NE, Richardson PJ, Olsen EGJ, Archard LC. Detection of coxsackie-B virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet. 1:1986;1120-1122.
17. Archard LC, Freeke CA, Richardson PJ, et al. Persistence of enterovirus RNA in dilated cardiomyopathy a progression from myocarditis . Schultheiß H-P. New Concepts in Viral Heart Disease. 1988;349-362 Springer-Verlag, Berlin.
18. Archard LC, Bowles NE, Cunningham L, et al. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur Heart J. 12 Suppl D:1991;56-59.
19. Jin O, Sole MJ, Butany JW, et al. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation. 82:1990;8-16.
20. Satoh M, Tamura G, Segawa I, Hiramori K, Satodate R. Enteroviral RNA in dilated cardiomyopathy. Eur Heart J. 15:1994;934-939.
21. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against β-adrenoreceptors in human idiopathic dilated cardiomyopathy. Circ Res. 64:1989;97-103.
22. Caforio ALP, Grazzini M, Mann JM, et al. Identification of α- and β-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation. 85:1992;1734-1742.
23. Lange LG, Schreiner GF. Immune cytokines and cardiac disease. Trends Cardiovasc Med. 2:1992;145-151.
24. Henke A, Mohr C, Sprenger H, et al. Coxsackievirus B3-induced production of tumor necrosis factor-α, IL-1β, and IL-6 in human monocytes. J Immunol. 148:1992;2270-2277.
25. Satoh M, Tamura G, Segawa I, Tashiro A, Satodate R, Hiramori K. Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy. Virchows Archiv. 427:1996;503-509.
26. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis mechanisms of endotoxin resistance . Science. 232:1986;977-980.
27. Urban JL, Shepard HM, Rothstein JL, Sugarman BJ. Tumor necrosis factor a potent effector molecule for tumor cell killing by activated macrophages . Proc Natl Acad Sci USA. 83:1986;5233-5237.
28. Kornbluth RS, Edgington TS. Tumor necrosis factor production by human monocytes is a regulated event induction of TNF-α-mediated cellular cytotoxicity by endotoxin . J Immunol. 137:1986;2585-2591.
29. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 347:1996;1151-1155.
30. Nakayama DK, Geller DA, Silvio MD, et al. Tetrahydrobiopterin synthase and inducible nitric oxide production in pulmonary artery smooth muscle. Am J Physiol. 266:1994;L455-60.
31. Balligand J-L, Ungureanu-Longrois D, Simmons WW, et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem. 269:1994;27580-27588.
32. Haywood GA, Tsao PS, von der Leyen HE, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 93:1996;1087-1094.
33. Thoenes M, Förstermann U, Tracey WR, et al. Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol. 28:1996;165-169.
34. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 92:1995;2198-2203.
35. Studer R, Hasenfuss G, Kastner S, Drexler H. Functional importance of myocardial gene expression of inducible nitric oxide synthase in ischemic and dilated cardiomyopathy [abstract]. Circulation. 92 Suppl I:1995;I-567.
36. Geng YJ, Hanson GK, Holme E. Interferon-γ and tumor necrosis factor synthesize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res. 71:1992;1268-1276.
37. Stuehr DJ, Nathan CE. Nitric oxide a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cell . J Exp Med. 169:1989;1543-1555.
38. Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor-β J Clin Invest. 95:1995;677-685.
39. Kitajima I, Kawahara K, Nakajima T, Soejima Y, Matsuyama T, Maruyama I. Nitric oxide-mediated apoptosis in murine mastocytoma. Biochem Biophys Res Commun. 204:1994;244-251.
40. Packer M. Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation. 92:1995;1379-1382.
41. Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704-711.
42. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 96:1995;1042-1052.
43. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest. 92:1993;2303-2312.
44. Lewis NP, Tsao PS, Rickenbacher PR, et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation. 93:1996;720-729.
45. Dudek RR, Wildhirt S, Conforto A, et al. Inducible nitric oxide synthase activity in myocardium after myocardial infarction in rabbit. Biochem Biophys Res Commun. 205:1994;1671-1680.
46. Wildhirt SM, Dudek RR, Suzuki H, Pinto V, Narayan KS, Bing RJ. Immunohistochemistry in the identification of nitric oxide synthase isoenzymes in myocardial infarction. Cardiovasc Res. 29:1995;526-531.